Dupilumab for treating adults with moderate to severe atopic dermatitis.

Rodolfo Andres Hernandez, Moira Cruickshank, Maria Petrova Dimitrova, David John Cooper, Lorna Sharman Aucott, Cynthia Fraser, Michal Shimonovich, Anthony Ormerod, Graham Stewart Scotland, Miriam Giovanna Brazzelli

Research output: Book/ReportCommissioned Report

Original languageEnglish
PublisherEvidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
VolumeTA534
Publication statusPublished - 1 Aug 2018

Cite this

Hernandez, R. A., Cruickshank, M., Dimitrova, M. P., Cooper, D. J., Aucott, L. S., Fraser, C., Shimonovich, M., Ormerod, A., Scotland, G. S., & Brazzelli, M. G. (2018). Dupilumab for treating adults with moderate to severe atopic dermatitis. Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ta534